{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:49:55Z","timestamp":1790567395547,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001170","name":"Cancer Council Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001170","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12885-016-2178-4","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T15:29:23Z","timestamp":1456327763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer"],"prefix":"10.1186","volume":"16","author":[{"given":"Gerard","family":"Hoyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Rudnicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Xiang","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Roycik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Howarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Leedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Candy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vance","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,24]]},"reference":[{"issue":"5","key":"2178_CR1","first-page":"E359","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. IJC. 2015;136(5):E359\u201386.","journal-title":"IJC"},{"issue":"1","key":"2178_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/35094009","volume":"1","author":"BJ Feldman","year":"2001","unstructured":"Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer. 2001;1(1):34\u201345.","journal-title":"Nat Rev Cancer"},{"issue":"21","key":"2178_CR3","first-page":"4687","volume":"57","author":"JR Gingrich","year":"1997","unstructured":"Gingrich JR, Barrios RJ, Kattan MW, Nahm HS, Finegold MJ, Greenberg NM. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Res. 1997;57(21):4687\u201391.","journal-title":"Cancer Res"},{"issue":"2","key":"2178_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0090-4295(02)02397-X","volume":"61","author":"CS Higano","year":"2003","unstructured":"Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology. 2003;61(2):32\u20138.","journal-title":"Urology"},{"issue":"1","key":"2178_CR5","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1021\/ar700108g","volume":"41","author":"RV Chari","year":"2008","unstructured":"Chari RV. Targeted cancer therapy: conferring specificity to cytotoxic drugs. Acc Chem Res. 2008;41(1):98\u2013107.","journal-title":"Acc Chem Res"},{"issue":"3","key":"2178_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000053160","volume":"51","author":"E Giovannucci","year":"1999","unstructured":"Giovannucci E. Insulin-like growth factor-I and binding protein-3 and risk of cancer. Horm Res. 1999;51(3):34\u201341.","journal-title":"Horm Res"},{"issue":"1","key":"2178_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/path.1492","volume":"202","author":"M Grzmil","year":"2004","unstructured":"Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression. J Pathol. 2004;202(1):50\u20139.","journal-title":"J Pathol"},{"issue":"7","key":"2178_CR8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tibs.2005.05.006","volume":"30","author":"APJ Huovila","year":"2005","unstructured":"Huovila APJ, Turner AJ, Pelto-Huikko M, K\u00e4rkk\u00e4inen I, Ortiz RM. Shedding light on ADAM metalloproteinases. Trends Biochem Sci. 2005;30(7):413\u201322.","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"2178_CR9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.eururo.2007.11.034","volume":"54","author":"FR Fritzsche","year":"2008","unstructured":"Fritzsche FR, Jung M, T\u00f6lle A, Wild P, Hartmann A, Wassermann K, et al. ADAM9 expression is a significant and independent prognostic marker of PSA relapse in prostate cancer. Eur Urol. 2008;54(5):1097\u2013108.","journal-title":"Eur Urol"},{"issue":"3","key":"2178_CR10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/pros.21237","volume":"71","author":"S Josson","year":"2011","unstructured":"Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, Hsieh CL, et al. Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate. 2011;71(3):232\u201340.","journal-title":"Prostate"},{"issue":"11","key":"2178_CR11","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1349-7006.2007.00601.x","volume":"98","author":"T Arima","year":"2007","unstructured":"Arima T, Enokida H, Kubo H, Kagara I, Matsuda R, Toki K, et al. Nuclear translocation of ADAM10 contributes to the pathogenesis and progression of human prostate cancer. Cancer Sci. 2007;98(11):1720\u20136.","journal-title":"Cancer Sci"},{"issue":"4","key":"2178_CR12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1593\/neo.05682","volume":"8","author":"R Kuefer","year":"2006","unstructured":"Kuefer R, Day KC, Kleer CG, Sabel MS, Hofer MD, Varambally S, et al. ADAM15 disintegrin is associated with aggressive prostate and breast cancer disease. Neoplasia. 2006;8(4):319\u201329.","journal-title":"Neoplasia"},{"issue":"5","key":"2178_CR13","first-page":"1714","volume":"40","author":"LJ Xiao","year":"2012","unstructured":"Xiao LJ, Lin P, Lin F, Liu X, Qin W, Zou HF, et al. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol. 2012;40(5):1714\u201324.","journal-title":"Int J Oncol"},{"issue":"20","key":"2178_CR14","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.2174\/138161209788682352","volume":"15","author":"B Qi","year":"2009","unstructured":"Qi B, Newcomer RG, Sang QXA. ADAM19\/adamalysin 19 structure, function, and role as a putative target in tumors and inflammatory diseases. Curr Pharm Des. 2009;15(20):2336\u201348.","journal-title":"Curr Pharm Des"},{"key":"2178_CR15","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1006\/bbrc.2000.4200","volume":"280","author":"P Wei","year":"2001","unstructured":"Wei P, Zhao Y-G, Zhuang L, Ruben S, Sang Q-XA. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19\/meltrin beta. Biochem Biophys Res Commun. 2001;280:744\u201355.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2178_CR16","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1074\/jbc.273.7.4180","volume":"273","author":"D Inoue","year":"1998","unstructured":"Inoue D, Reid M, Lum L, Kratzschmar J, Weskamp G, Myung YM, et al. Cloning and Initial characterization of mouse meltrin b and analysis of the expression of four metalloprotease-disintegrins in bone cells. J Biol Chem. 1998;273(7):4180\u20137.","journal-title":"J Biol Chem"},{"issue":"2","key":"2178_CR17","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0925-4773(98)00043-4","volume":"73","author":"T Kurisakia","year":"1998","unstructured":"Kurisakia T, Masudaa A, Osumib N, Nabeshimaa Y-i, Fujisawa-Seharaa A. Spatially- and temporally-restricted expression of meltrin a (ADAM12) and b (ADAM19) in mouse embryo. Mech Dev. 1998;73(2):211\u20135.","journal-title":"Mech Dev"},{"issue":"1","key":"2178_CR18","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1128\/MCB.24.1.96-104.2004","volume":"24","author":"HM Zhou","year":"2004","unstructured":"Zhou HM, Weskamp G, Chesneau V, Sahin U, Vortkamp A, Horiuchi K, et al. Essential role for ADAM19 in cardiovascular morphogenesis. Mol Cell Biol. 2004;24(1):96\u2013104.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2178_CR19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00421-005-1333-4","volume":"94","author":"NK LeBrasseur","year":"2005","unstructured":"LeBrasseur NK, Mizer KC, Parkington JD, Sawyer DB, Fielding RA. The expression of neuregulin and erbB receptors in human skeletal muscle: effects of progressive resistance training. Eur J Appl Physiol. 2005;94(4):371\u20135.","journal-title":"Eur J Appl Physiol"},{"issue":"10","key":"2178_CR20","doi-asserted-by":"crossref","first-page":"4982","DOI":"10.1091\/mbc.E05-03-0258","volume":"16","author":"J Huang","year":"2005","unstructured":"Huang J, Bridges LC, White JM. Selective modulation of integrin-mediated cell migration by distinct ADAM family members. Mol Biol Cell. 2005;16(10):4982\u201391.","journal-title":"Mol Biol Cell"},{"issue":"8","key":"2178_CR21","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1158\/0008-5472.CAN-09-3761","volume":"70","author":"B Garmy-Susini","year":"2010","unstructured":"Garmy-Susini B, Avraamides CJ, Schmid MC, Foubert P, Ellies LG, Barnes L, et al. Integrin \u03b14\u03b21 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res. 2010;70(8):3042\u201351.","journal-title":"Cancer Res"},{"key":"2178_CR22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bbrc.2001.5958","volume":"289","author":"Y-G Zhao","year":"2001","unstructured":"Zhao Y-G, Wei P, Sang Q-XA. Inhibitory antibodies against endopeptidase activity of human adamalysin 19. Biochem Biophys Res Commun. 2001;289:288\u201394.","journal-title":"Biochem Biophys Res Commun"},{"issue":"50","key":"2178_CR23","doi-asserted-by":"crossref","first-page":"48514","DOI":"10.1074\/jbc.M208961200","volume":"277","author":"T Kang","year":"2002","unstructured":"Kang T, Park H, Suh Y, Zhao Y, Tschesche H, Sang Q. Autolytic processing at Glu586-Ser587 within the cysteine-rich domain of human adamalysin 19\/disintegrin-metalloproteinase 19 is necessary for its proteolytic activity. J Biol Chem. 2002;277(50):48514\u201322.","journal-title":"J Biol Chem"},{"issue":"9","key":"2178_CR24","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1046\/j.1432-1327.2000.01278.x","volume":"267","author":"K Althoff","year":"2000","unstructured":"Althoff K, Reddy P, Voltz N, Rose-John S, M\u00fcllberg J. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur J Biochem. 2000;267(9):2624\u201331.","journal-title":"Eur J Biochem"},{"issue":"2","key":"2178_CR25","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","volume":"2","author":"C Liang","year":"2007","unstructured":"Liang C, Park AY, Guan J. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc. 2007;2(2):329\u201333.","journal-title":"Nat Protoc"},{"issue":"4","key":"2178_CR26","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1139\/O09-015","volume":"87","author":"A Hikita","year":"2009","unstructured":"Hikita A, Tanaka N, Yamane S, Ikeda Y, Furukawa H, Tohma S, et al. Involvement of A Disintegrin and Metalloproteinase 10 and 17 in shedding of tumor necrosis factor-\u03b1. Biochem Cell Biol. 2009;87(4):581\u201393.","journal-title":"Biochem Cell Biol"},{"issue":"3","key":"2178_CR27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/MIB.0b013e31828028e8","volume":"19","author":"E Franz\u00e8","year":"2013","unstructured":"Franz\u00e8 E, Caruso R, Stolfi C, Sarra M, Cupi M, Ascolani M, et al. High expression of the \u201cA Disintegrin And Metalloprotease\u201d 19 (ADAM19), a sheddase for TNF-\u03b1 in the mucosa of patients with inflammatory bowel diseases. Inflamm Bowel Dis. 2013;19(3):501\u201311.","journal-title":"Inflamm Bowel Dis"},{"issue":"9","key":"2178_CR28","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1593\/neo.08540","volume":"10","author":"M Chan","year":"2008","unstructured":"Chan M, Huang Y, Hartman-Frey C, Kuo C, Deatherage D, Qin H, et al. Aberrant transforming growth factor \u03b21 signaling and SMAD4 nuclear translocation confer epigenetic repression of ADAM19 in ovarian cancer. Neoplasia. 2008;10(9):908.","journal-title":"Neoplasia"},{"issue":"7","key":"2178_CR29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1038\/sj.ki.5001753","volume":"70","author":"W Melenhorst","year":"2006","unstructured":"Melenhorst W, Heuvel M, Timmer A, Huitema S, Bulthuis M, Timens W, et al. ADAM19 expression in human nephrogenesis and renal disease: associations with clinical and structural deterioration. Kidney Int. 2006;70(7):1269\u201378.","journal-title":"Kidney Int"},{"issue":"5","key":"2178_CR30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/01.jnen.0000229240.51490.d3","volume":"65","author":"D Wildeboer","year":"2006","unstructured":"Wildeboer D, Naus S, Sang Q, Bartsch J, Pagenstecher A. Metalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol. 2006;65(5):516\u201327.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"12","key":"2178_CR31","doi-asserted-by":"crossref","first-page":"9352","DOI":"10.1074\/jbc.M007913200","volume":"276","author":"K Shirakabe","year":"2001","unstructured":"Shirakabe K, Wakatsuki S, Kurisaki T, Fujisawa-Sehara A. Roles of Meltrin \u03b2\/ADAM19 in the processing of neuregulin. J Biol Chem. 2001;276(12):9352\u20138.","journal-title":"J Biol Chem"},{"issue":"25","key":"2178_CR32","doi-asserted-by":"crossref","first-page":"22331","DOI":"10.1074\/jbc.M302781200","volume":"278","author":"V Chesneau","year":"2003","unstructured":"Chesneau V, Becherer J, Zheng Y, Erdjument-Bromage H, Tempst P, Blobel C. Catalytic properties of ADAM19. J Biol Chem. 2003;278(25):22331\u201340.","journal-title":"J Biol Chem"},{"issue":"4","key":"2178_CR33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.bbrc.2010.05.025","volume":"396","author":"C Tanabe","year":"2010","unstructured":"Tanabe C, Hotoda N, Sasagawa N, Futai E, Komano H, Ishiura S. ADAM19 autolysis is activated by LPS and promotes non-classical secretion of cysteine-rich protein 2. Biochem Biophys Res Commun. 2010;396(4):927\u201332.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2178_CR34","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ydbio.2003.10.021","volume":"267","author":"K Kurohara","year":"2004","unstructured":"Kurohara K, Komatsu K, Kurisaki T, Masuda A, Irie N, Asano M, et al. Essential roles of Meltrin \u03b2 (ADAM19) in heart development. Dev Biol. 2004;267(1):14\u201328.","journal-title":"Dev Biol"},{"issue":"18","key":"2178_CR35","doi-asserted-by":"crossref","first-page":"6950","DOI":"10.1128\/MCB.00646-06","volume":"26","author":"C Chen","year":"2006","unstructured":"Chen C, Huang X, Sheppard D. ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice. Mol Cell Biol. 2006;26(18):6950\u20136.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"2178_CR36","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1161\/CIRCULATIONAHA.107.690487","volume":"116","author":"K Lemmens","year":"2007","unstructured":"Lemmens K, Doggen K, Keulenaer GD. Role of neuregulin-1\/ErbB signaling in cardiovascular physiology and disease implications for therapy of heart failure. Circulation. 2007;116(8):954\u201360.","journal-title":"Circulation"},{"issue":"22","key":"2178_CR37","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/sj.onc.1201447","volume":"15","author":"A Grasso","year":"1997","unstructured":"Grasso A, Wen D, Miller C, Rhim J, Pretlow T, Kung H. ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene. 1997;15(22):2705\u201316.","journal-title":"Oncogene"},{"issue":"1","key":"2178_CR38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1471-4159.2003.02303.x","volume":"89","author":"S Wakatsuki","year":"2004","unstructured":"Wakatsuki S, Kurisaki T, Sehara-Fujisawa A. Lipid rafts identified as locations of ectodomain shedding mediated by Meltrin \u03b2\/ADAM19. J Neurochem. 2004;89(1):119\u201323.","journal-title":"J Neurochem"},{"issue":"2","key":"2178_CR39","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2003.09.016","volume":"203","author":"D Chopra","year":"2004","unstructured":"Chopra D, Menard R, Januszewski J, Mattingly R. TNF-\u03b1-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett. 2004;203(2):145\u201354.","journal-title":"Cancer Lett"},{"issue":"45","key":"2178_CR40","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1038\/sj.onc.1208833","volume":"24","author":"O Rokhlin","year":"2005","unstructured":"Rokhlin O, Taghiyev A, Guseva N, Glover R, Chumakov P, Kravchenko J, et al. Androgen regulates apoptosis induced by TNFR family ligands via multiple signaling pathways in LNCaP. Oncogene. 2005;24(45):6773\u201384.","journal-title":"Oncogene"},{"issue":"20","key":"2178_CR41","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1073\/pnas.1101747108","volume":"108","author":"A Cheung","year":"2011","unstructured":"Cheung A, Ko J, Lung H, Chan K, Stanbridge E, Zabarovsky E, et al. Cysteine-rich intestinal protein 2 (CRIP2) acts as a repressor of NF-\u03baB\u2013mediated proangiogenic cytokine transcription to suppress tumorigenesis and angiogenesis. Proc Natl Acad Sci U S A. 2011;108(20):8390\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"2178_CR42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2011.10.020","volume":"316","author":"P Lo","year":"2012","unstructured":"Lo P, Ko J, Yu Z, Law S, Wang L, Li J, et al. The LIM domain protein, CRIP2, promotes apoptosis in esophageal squamous cell carcinoma. Cancer Lett. 2012;316(1):39\u201345.","journal-title":"Cancer Lett"},{"key":"2178_CR43","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jclinpath-2015-203001","volume":"68","author":"MF Gallagher","year":"2015","unstructured":"Gallagher MF, Salley Y, Spillane CD, Ffrench B, Baruni SE, Blacksheilds G, et al. Enhanced regulation of cell cycle and suppression of osteoblast differentiation molecular signatures by prostate cancer stem-like holoclones. J Clin Path. 2015;68:692\u2013702.","journal-title":"J Clin Path"},{"issue":"2","key":"2178_CR44","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/geno.1996.0028","volume":"31","author":"MK MA","year":"1996","unstructured":"MA MK, Ohta K, Egashira M, Jinno Y, Niikawa N, Matsuda I, et al. Human ESP1\/CRP2, a member of the LIM domain protein family: characterization of the cDNA and assignment of the gene locus to chromosome 14q32.3. Genomics. 1996;31(2):167\u201376.","journal-title":"Genomics"},{"issue":"1","key":"2178_CR45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0303-7207(02)00287-3","volume":"199","author":"X Shen","year":"2003","unstructured":"Shen X, Falzon M. PTH-related protein modulates PC-3 prostate cancer cell adhesion and integrin subunit profile. Mol Cell Endo. 2003;199(1):165\u201377.","journal-title":"Mol Cell Endo"},{"key":"2178_CR46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.juro.2015.10.172","volume":"195","author":"JC Angulo","year":"2016","unstructured":"Angulo JC, Adres G, Ashour N, Sanchez-Chapado M, Lopez JI, Ropero S. Development of castration resistant prostate cancer can be predicted by a DNA hypermethylation profile. J Urol. 2016;195:1\u20138.","journal-title":"J Urol"},{"issue":"3","key":"2178_CR47","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1161\/CIRCGENETICS.113.000066","volume":"7","author":"S London","year":"2014","unstructured":"London S, Gao W, Gharib S, Hancock D, Wilk J, House J, et al. ADAM19 and HTR4 variants and pulmonary function: cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium targeted sequencing study. Circ Cardiovasc Genet. 2014;7(3):350\u20138.","journal-title":"Circ Cardiovasc Genet"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-016-2178-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T02:43:03Z","timestamp":1498272183000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.biomedcentral.com\/1471-2407\/16\/151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,24]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["2178"],"URL":"https:\/\/doi.org\/10.1186\/s12885-016-2178-4","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,24]]},"article-number":"151"}}